summary
Introduced
05/09/2018
05/09/2018
In Committee
05/23/2018
05/23/2018
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
BEST Act Benefit Evaluation of Safe Treatment Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans.
AI Summary
This bill, the Benefit Evaluation of Safe Treatment (BEST) Act of 2018, requires the Centers for Medicare & Medicaid Services (CMS) to report to Congress on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans. The report will analyze the extent to which MA plans offer benefits related to medication-assisted treatment, substance use disorder counseling, peer recovery support services, non-opioid pain treatment, and the challenges associated with these benefits. It will also examine the potential impact of increasing the applicable rebate percentage on the availability of these supplemental benefits in MA plans and ways to improve or incentivize such coverage.
Committee Categories
Budget and Finance, Health and Social Services
Sponsors (4)
Last Action
Referred to the Subcommittee on Health. (on 05/23/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/115th-congress/house-bill/5725/all-info |
| BillText | https://www.congress.gov/115/bills/hr5725/BILLS-115hr5725ih.pdf |
| Bill | https://www.congress.gov/115/bills/hr5725/BILLS-115hr5725ih.pdf.pdf |
Loading...